Eikon Therapeutics
Pioneering a new method of drug discovery based on tracking and measuring movement of individual proteins in live cells
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells.
By directly measuring the effects of chemical compounds on the behavior of protein molecules in a live cellular environment, Eikon’s landmark assays facilitate the highly sensitive identification of compound-protein interactions that could not be identified through traditional assays, thereby unlocking otherwise intractable classes of proteins as drug targets. Furthermore, the ability to directly visualize protein mechanisms in disease coupled with the extraordinarily high-powered high-content data sets generated by Eikon’s drug-screening technology enable an unprecedented opportunity to quantitatively explore novel biology in the living cell. These insights facilitate creation and application of data-driven hypotheses to the discovery of life-saving therapies.
The Opportunity
Executive Director of Regulatory Affairs
-
Video with Hiring Manager
-
Overview
The Overview of the position will be tailored to the information the Hiring Manager shares with us during Needs Analysis Profile meeting.
-
Responsibilities
We will customize the Responsibilities section based on the information we receive from the hiring manager during the Needs Analysis Profile meeting.
-
Qualifications
We will customize the Qualifications section based on the information we receive from the hiring manager during the Needs Analysis Profile meeting.